This Article Full Text Full Text (PDF) All Versions of this Article: 145/9/4078    most recent Author Manuscript (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by MacDonald, P. E. Articles by Wheeler, M. B. Search for Related Content PubMed PubMed Citation Articles by MacDonald, P. E. Articles by Wheeler, M. B.

Impaired Glucose-Stimulated Insulin Secretion, Enhanced Intraperitoneal Insulin Tolerance, and Increased ß-Cell Mass in Mice Lacking the p110 Isoform of Phosphoinositide 3-Kinase

University of Toronto (P.E.M., J.W.J., D.Y., J.D., Z.A., F.D., M.B.W.), Departments of Physiology and Medicine, Toronto, Canada; Lund University (P.E.M.), Department of Molecular and Cellular Physiology, Lund 221 84, Sweden; and Division of Cardiology (G.Y.O., M.M.P., P.H.B.), University Health Network and the Heart and Stroke Richard Lewar Centre of Excellence, Toronto, Canada M5S 3E2

Address all correspondence and requests for reprints to: Dr. P. E. MacDonald, Lund University, Department of Molecular and Cellular Physiology, Tornavägen 10, BMC B11, 221 84 Lund, Sweden. E-mail: patrick.macdonald{at}mphy.lu.se.

Phosphoinositide 3-kinase (PI3 kinase) has been implicated in G protein-coupled receptor regulation of pancreatic ß-cell growth and glucose-stimulated insulin secretion. The G protein-activated p110 isoform of PI3 kinase was detected in insulinoma cells, mouse islets, and human islets. In 7- to 10-wk-old mice, knockout of p110 reduced the plasma insulin response to ip glucose injection and impaired first and second phase glucose-stimulated insulin secretion from pancreata perfused ex vivo. The p110 –/– mice responded to preinjection with the glucagon-like peptide-1 receptor agonist exendin 4, such that plasma glucose and insulin responses to ip glucose injection were not different from wild types. Mice lacking p110 were not diabetic and were only slightly glucose intolerant (ip glucose injection) compared with wild types, in part due to enhanced responsiveness to insulin as determined by an ip insulin tolerance test. Despite severely reduced insulin secretion in these animals, the p110 –/– mice had greater pancreatic insulin content, and an increased ß-cell mass due to ß-cell hypertrophy. These surprising results suggest that the G protein-coupled p110 isoform of PI3 kinase is not central to the development or maintenance of sufficient ß-cell mass but positively regulates glucose-stimulated insulin secretion.

This article has been cited by other articles:

				H. Cheng, S. G. Straub, and G. W. G. Sharp Inhibitory role of Src family tyrosine kinases on Ca2+-dependent insulin release Am J Physiol Endocrinol Metab, March 1, 2007; 292(3): E845 - E852. [Abstract] [Full Text] [PDF]

				L.-X. Li, P. E. MacDonald, D. S. Ahn, G. Y. Oudit, P. H. Backx, and P. L. Brubaker Role of Phosphatidylinositol 3-Kinase{gamma} in the {beta}-Cell: Interactions with Glucagon-Like Peptide-1 Endocrinology, July 1, 2006; 147(7): 3318 - 3325. [Abstract] [Full Text] [PDF]

				F. B. Hickey and T. G. Cotter BCR-ABL Regulates Phosphatidylinositol 3-Kinase-p110{gamma} Transcription and Activation and Is Required for Proliferation and Drug Resistance J. Biol. Chem., February 3, 2006; 281(5): 2441 - 2450. [Abstract] [Full Text] [PDF]